UA94107C2 - Stabilized pharmaceutical composition comprising fesoterodine - Google Patents
Stabilized pharmaceutical composition comprising fesoterodineInfo
- Publication number
- UA94107C2 UA94107C2 UAA200900167A UAA200900167A UA94107C2 UA 94107 C2 UA94107 C2 UA 94107C2 UA A200900167 A UAA200900167 A UA A200900167A UA A200900167 A UAA200900167 A UA A200900167A UA 94107 C2 UA94107 C2 UA 94107C2
- Authority
- UA
- Ukraine
- Prior art keywords
- fesoterodine
- pharmaceutical composition
- stabilized pharmaceutical
- stabilized
- isomalt
- Prior art date
Links
- DCCSDBARQIPTGU-HSZRJFAPSA-N fesoterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(CO)C=2)OC(=O)C(C)C)=CC=CC=C1 DCCSDBARQIPTGU-HSZRJFAPSA-N 0.000 title abstract 2
- 229960002978 fesoterodine Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 abstract 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229920001100 Polydextrose Polymers 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 239000008121 dextrose Substances 0.000 abstract 1
- 239000000905 isomalt Substances 0.000 abstract 1
- 235000010439 isomalt Nutrition 0.000 abstract 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 239000001259 polydextrose Substances 0.000 abstract 1
- 229940035035 polydextrose Drugs 0.000 abstract 1
- 235000013856 polydextrose Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 229960002920 sorbitol Drugs 0.000 abstract 1
- 235000010356 sorbitol Nutrition 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present application relates to a pharmaceutical composition comprising fesoterodine or a pharmaceutically acceptable salt or solvate thereof and a stabilizer selected from the group consisting of xylitol, sorbitol, polydextrose, isomalt and dextrose.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06011941 | 2006-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94107C2 true UA94107C2 (en) | 2011-04-11 |
Family
ID=50831844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200900167A UA94107C2 (en) | 2006-06-09 | 2007-06-06 | Stabilized pharmaceutical composition comprising fesoterodine |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR109053A2 (en) |
| UA (1) | UA94107C2 (en) |
-
2007
- 2007-06-06 UA UAA200900167A patent/UA94107C2/en unknown
-
2017
- 2017-07-14 AR ARP170101964A patent/AR109053A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR109053A2 (en) | 2018-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY146574A (en) | Stabilized pharmaceutical compositions comprising fesoterodine | |
| AU2007299727A8 (en) | Self preserved aqueous pharmaceutical compositions | |
| WO2011044501A3 (en) | Antibacterial aminoglycoside analogs | |
| WO2007124465A3 (en) | Stable emulsion formulations | |
| IL198301A (en) | Thiazole and oxazole-substituted arylamides, pharmaceutical compositions comprising them and their use for preparing medicaments | |
| AP2714A (en) | Orodispersible pharmaceutical composition for or omucosal or sublingual administration of agomelati ne | |
| WO2006082523A3 (en) | Pharmaceutical sustained release composition of metformin | |
| UA93709C2 (en) | 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions | |
| WO2008003050A3 (en) | Gallium nitrate formulations | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| WO2008075320A3 (en) | Antilipidemic pharmaceutical compositions and process for preparation thereof | |
| WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
| ZA200901164B (en) | Self preserved aqueous pharmaceutical compositions | |
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| WO2007110765A3 (en) | Processes for the preparation of octreotide | |
| WO2009053654A3 (en) | Gemcitabine phosphoester prodrugs as anticancer agents | |
| WO2010029093A3 (en) | Compositions for percutaneous administration | |
| IL194094A0 (en) | Stable pharmacuetical compositions of 2-aza-bicyclol[3.3.0]-octane-3-carboxylic acid derivatives | |
| UA94107C2 (en) | Stabilized pharmaceutical composition comprising fesoterodine | |
| TW200640472A (en) | Solid pharmaceutical composition comprising telithromycin | |
| ZA201005394B (en) | 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative | |
| EP1948199A4 (en) | Pharmaceutical compositions for the administration of aptamers | |
| DOP2008000067A (en) | STABILIZED PHARMACEUTICAL COMPOSITIONS THAT INCLUDE FESOTERODINE. | |
| IL179816A0 (en) | Use of an invertebrate pheromones for the preparation of a medicament and pharmaceutical compositions thereof | |
| CR20140109S (en) | STABILIZING PHARMACEUTICAL COMPOSITIONS THAT INCLUDE FESOTERODINE |